Patent Number: 6,251,634

Title: Pseudorabies virus protein

Abstract: The present invention provides recombinant DNA molecules comprising a sequence encoding a pseudorabies virus (PRV) glycoprotein selected from the group consisting of gI, gp50, and gp63, host cells transformed by said recombinant DNA molecule sequences, the gI, gp50 and gp63 polypeptides. The present invention also provides subunit vaccines for PRV, methods for protecting animals against PRV infection and methods for distinguishing between infected and vaccinated animals.

Inventors: Petrovskis; Erik Aivars (Kalamazoo, MI), Post; Leonard Edwin (Kalamazoo, MI), Timmins; James G. (Naperville, IL)

Assignee: Pharmacia & Upjohn Company

International Classification: C07K 14/03 (20060101); C07K 14/005 (20060101); G01N 33/569 (20060101); A61K 39/00 (20060101); C12N 015/38 (); C12N 005/10 ()

Expiration Date: 06/26/2018